VAT Group AG (VACN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 570.00 |
|---|---|
| 52-week range | 305.10 – 727.20 |
| Return, 1 month / 3 months | −13.6% / −11.4% |
| Return, 1 year / 3 years | +77.4% / +88.7% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 42.5% |
| Worst drawdown (1 year) | -20.0% |
| Average daily value traded | 42.29M CHF |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
VAT Group AG designs and makes vacuum valves and related vacuum components, including gate valves, angle valves and sealing technology used to control gas flows in enclosed environments. Its customers are manufacturers in the semiconductor industry and other industrial sectors that rely on vacuum processes, such as coating and analysis equipment. The company is based in Switzerland and supplies its products to equipment makers and industrial users around the world.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code VACN, and the price on this page is in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
VAT Group AG (VACN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 570.00 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 110 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 77.4% and over the last three months it fell 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.0% | ||
| From 52-week high | -19.7% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -11.4% | ||
| 6-month return | -1.8% | ||
| 12-month return, skipping the last month | 105.2% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.0% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 42.29M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −8.6% |
|---|---|
| 1 month | −13.6% |
| 3 months | −11.4% |
| 6 months | −1.8% |
| 1 year | +77.4% |
| 3 years | +88.7% |
| 5 years | +42.4% |
Signals
| 50-day / 200-day average | 629.16 / 587.83 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 22.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | CHF 7.0000 |
| 2 May 2025 | CHF 6.2500 |
| 16 May 2024 | CHF 6.2500 |
| 19 May 2023 | CHF 6.2500 |
| 19 May 2022 | CHF 0.2500 |
| 20 May 2021 | CHF 2.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.